Table 2.

Endpoint events in the study cohort at 30 days

Events	Non-CS (n = 562)	CS on admission (n = 32)	Developed CS (n = 81)	p-value
All cause death, n (%)	13(2)	1(3)	2(2)	0.956
MACE
Cardiac death, n (%)	13(2)	1(3)	2(2)	0.956
Angina/Recurrent MI, n (%)	4(1)	0(0)	0(0)	0.667
Worsening of cardiac function, n (%)	2(0)	1(3)	1(1)	0.101
Non-fatal stroke, n (%)	0(0)	1(3)	0(0)	P < 0.001

MI Myocardial infarction, MACE Major adverse cardiac events